Novo Nordisk Recalls Insulin Diluting Medium Due to Temperature Abuse
Novo Nordisk is recalling specific samples of Insulin Diluting Medium for NovoLog because they were stored below 32°F, potentially causing lack of efficacy and damage to the cartridge and pen-injectors.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 per the rubric, as it represents a reasonable probability of serious adverse health consequences or death due to lack of efficacy in a critical medication.
Plain-English summary
Novo Nordisk Inc. is recalling specific samples of INSULIN DILUTING MEDIUM FOR NOVOLOG (WATER INJECTION). The affected product is the NovoLog FlexPen (insulin aspart) Injection, 100 units/mL, 3 mL Prefilled Insulin Syringe pen, Sample. The specific lot code is KS6BS11 with an expiration date of 11/30/2021. The product is distributed nationwide in the USA.
The recall was initiated because the product samples were stored at temperatures below 32°F, which does not comply with storage requirements. This temperature abuse could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Consumers and healthcare providers should check their inventory for the specific lot code KS6BS11 and expiration date 11/30/2021. If the product matches these details, it should be removed from use and returned to the distributor or manufacturer according to standard recall procedures.
The recalled product
- Product
- INSULIN DILUTING MEDIUM FOR NOVOLOG (WATER INJECTION)
- Brand
- INSULIN DILUTING MEDIUM FOR NOVOLOG
- Manufacturer
- Novo Nordisk Inc
- Category
- Drug — Insulin
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- KS6BS11
- Exp 11/30/2021
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by Novo Nordisk Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same brand · INSULIN DILUTING MEDIUM FOR NOVOLOG
- SevereNovo Nordisk Recalls Insulin Diluting Medium Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
Same manufacturer · Novo Nordisk Inc
See all →- HighWegovy 0.5 mg pens recalled after hair was found in a syringe
FDA (Drugs) · 2026-01-07
- HighWegovy prefilled pens recalled after hair was found in a syringe
FDA (Drugs) · 2026-01-07
- ModerateNovo Nordisk Recalls OZEMPIC Injection Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls TRESIBA Insulin Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls Fiasp Insulin Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
Same hazard · lack of efficacy
See all →- SevereNovo Nordisk Recalls TRESIBA Insulin Samples Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- ModerateNovo Nordisk Recalls Victoza Injection Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- ModerateNovo Nordisk Recalls Saxenda Injection Samples Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls Fiasp Insulin Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21